Displaying 151 - 155 of 155 results
Released Company Title Industry Topic
11 Sep 2023
07:00 CEST
BERGENBIO BerGenBio to Present Company Update at H.C. Wainright Annual Global Investment Conference 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
27 Aug 2023
20:35 CEST
BERGENBIO Correction: BerGenBio ASA Seccond Quarter and half year 2023 Financial Report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
23 Aug 2023
07:00 CEST
BERGENBIO BerGenBio Reports Second Quarter 2023 Financial Results 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
22 Aug 2023
10:30 CEST
BERGENBIO BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
16 Aug 2023
07:00 CEST
BERGENBIO BerGenBio ASA: Invitation to second quarter and half year 2023 results webcast 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State